HOME > Chiesi España > Chiesi Spain News
 
-
-
1/11
Balanced nutrition helps prevent decompensation in COPD
2/11
-
3/11
ARCHIVE NEWS
-
-
-
-
CHIESI ENTERS INTO AN EXCLUSIVE EX-US PARTNERSHIP WITH PROTALIX BIOTHERAPEUTICS FOR THE DEVELOPMENT AND COMMERCIALIZATION OF PRX-102 (PEGUNIGALSIDASE ALFA) FOR THE TREATMENT OF FABRY DISEASE
Chiesi Group receives the European Marketing Authorisation for Trimbow® (ICS/LABA/LAMA)
-
Respiration Day 2017
Trimbow® is the first triple combination in a single inhaler for the treatment of COPD to receive positive opinion from the CHMP in Europe
-
GLYBERA▼ (ALIPOGENE TIPARVOVEC) IN EUROPE
Chiesi and Molecular Warehouse join forces to create innovative diagnostic tool for transplant patients
Chiesi grants the startup New Born Solutions to participate in the immersion program of Richi Social Entrepreneurs in Boston
Publicado el segundo número de la revista NewsRARE sobre Registros de Pacientes y Medicamentos Huérfanos
-
-
-
-
-
The Lancet publishes the results of Chiesi Farmaceutici TRILOGY study, which shows one year data on the superior efficacy of the first extrafine fixed ICS/LABA/LAMA triple combination for COPD treatment compared with standard therapy
España es uno de los países líderes mundiales en investigación neumológica
FlogoSport ayudando a los deportistas en su rendimiento físico en la carrera “The Mud Day” Sevilla
TicSalut y Chiesi apuestan por modernizar los servicios sanitarios
Los cuidados informales de la EPOC permiten ahorrar hasta 40.000 euros anuales por paciente al sistema sanitario
Beatriz Vila, Directora de Personas de Chiesi ha sido premiada en la categoría de HR Director